About ClinArt Mena
ClinArt Mena is a company based in Dubai (United Arab Emirates) founded in 2001 was acquired by CTI Clinical Trial in September 2020. ClinArt Mena offers products and services including Therapeutic Areas Services, Regulatory Development, Clinical Services, and Lab Services. ClinArt Mena operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Dubai, United Arab Emirates
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Kuwait Life Sciences Company
& 1 more
-
Employee Count
Not available
-
Acquired by
CTI Clinical Trial
(Sep 16, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ClinArt Mena
ClinArt Mena offers a comprehensive portfolio of products and services, including Therapeutic Areas Services, Regulatory Development, Clinical Services, and Lab Services.
Manages research in rare diseases and immunology.
Provides strategic consulting for drug approvals.
Oversees study start-up and medical monitoring.
Conducts safety testing and biorepository management.
Funding Insights of ClinArt Mena
Investors in ClinArt Mena
ClinArt Mena has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Kuwait Life Sciences Company and CTI Clinical Trial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Kuwait Life Sciences Company is engaged in healthcare investments and technology transfer in the MENA region.
|
Locked | Locked | Locked | |
|
Provides clinical trials, consulting, and regulatory services in healthcare sectors.
|
Locked | Locked | Locked |
Investor details for ClinArt Mena
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ClinArt Mena
Investment portfolio details for ClinArt Mena
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ClinArt Mena
Detailed financials for ClinArt Mena
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clinart Mena Comparisons
Peer comparison for ClinArt Mena
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ClinArt Mena
ClinArt Mena operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of ClinArt Mena
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clinart Mena
Complete news archive for ClinArt Mena
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ClinArt Mena
ClinArt Mena was founded in 2001 and raised its 1st funding round 10 years after it was founded.
ClinArt Mena is headquartered in Dubai, United Arab Emirates. It is registered at Dubai, Dubai, United Arab Emirates.
Founded in 2001 and headquartered in Dubai, United Arab Emirates, ClinArt Mena operates as a contract research organization in the clinical trials sector. Services encompass clinical project management, site monitoring, data management, medical monitoring and writing, quality assurance, biostatistics, and patient selection across therapeutic areas including oncology, cardiovascular diseases, and infectious diseases. Over 700 patients have been recruited for phase II-III studies, with approximately 8,000 patients enrolled in non-interventional studies.
ClinArt Mena's top competitors include Emmes, Syneos Health and ClinChoice.
ClinArt Mena offers Therapeutic Areas Services, Regulatory Development, Clinical Services, and Lab Services.
ClinArt Mena has 2 investors. Key investors include Kuwait Life Sciences Company, and CTI Clinical Trial.